Infanrix Polio (Pertussis Filamentous Haemagglutinin Adsorbed On Aluminium Hydroxide, Hydrated, Pertussis Toxoid Ads)

The vaccine contains toxoid forms of diphtheria and tetanus, acellular pertussis antigens, and inactivated poliovirus, all adsorbed onto aluminium hydroxide. After injection, antigen‑presenting cells process these components, activating T‑cells and prompting B‑cells to generate IgG antibodies. The aluminium adjuvant amplifies this response, creating durable immunity.

The dose and schedule of Infanrix Polio are determined by the prescribing healthcare professional based on national immunisation guidelines. Typically, the vaccine is given as a series of intramuscular injections in the thigh or upper arm of infants, but exact timing and number of doses should follow the clinician’s recommendation.

Infanrix Polio is generally not administered to pregnant women because it is intended for infant immunisation. Limited data are available regarding its safety in pregnancy, so it is usually avoided unless a clear benefit outweighs potential risks. Breastfeeding mothers may receive the vaccine, but they should discuss any concerns with their healthcare provider.

To order Infanrix Polio, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and any necessary import documentation.

Infanrix Polio combines diphtheria, tetanus, acellular pertussis and inactivated poliovirus antigens in a single injection, reducing the number of separate shots required. Compared with older whole‑cell pertussis vaccines, the acellular formulation tends to cause fewer local reactions while maintaining protective efficacy. It aligns with many national immunisation schedules that favour combined DTaP‑IPV products.

Infanrix Polio must be stored at 2‑8 °C (refrigerated) and protected from light. The vial should remain in its original packaging, should not be frozen, and must not be shaken vigorously. If the vaccine has been exposed to temperatures outside this range, it should be discarded according to the supplier’s guidelines.

The vaccine is given as an intramuscular injection, usually into the anterolateral thigh of infants or the deltoid muscle of older children. Administration is performed by a qualified healthcare professional using aseptic technique. The injection site should be observed for a short period after vaccination to monitor for immediate reactions.

While rare, serious adverse events can include severe allergic reactions (anaphylaxis), high‑grade fever, seizures, or neurological events such as encephalopathy. Caregivers should seek immediate medical attention if the child experiences difficulty breathing, persistent high fever, prolonged crying, or any signs of a severe reaction after vaccination.

Infanrix Polio should be avoided in individuals with a known severe allergy to any component of the vaccine, including aluminium hydroxide or the specific toxoids. It is also contraindicated in persons with a history of severe anaphylactic reaction to a previous dose of the same vaccine. Consultation with a healthcare professional is essential for those with immunodeficiency or other special conditions.